Search - tctmd.com

Displaying 121 - 140 of 259

Sort: Relevancy | Date

Presentation TCT 2015

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Roxana Mehran

October 14, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 4 Academia Perspectives

Presenter: Roxana Mehran, Laura Mauri

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 3 Industry Perspectives

Presenter: Roxana Mehran, Keith D. Dawkins

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 2 EMA Perspectives

Presenter: Roxana Mehran, Angeles Alonso Garcia

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 1 FDA Perspectives

Presenter: Roxana Mehran, John C Laschinger

October 13, 2015

Presentation TCT 2015

Is the Answer Pragmatic/Simple Trials? Are They Really So Simple?

Presenter: Roxana Mehran, Robert A. Harrington

October 13, 2015

Presentation TCT 2015

KEYNOTE LECTURE: Redefining Clinical Research and Patient Care: The New Era of Big Data, Precision Medicine, and Digital Health

Presenter: Roxana Mehran, Bram D. Zuckerman, Aaron V. Kaplan, Robert A. Harrington

October 13, 2015

Presentation TCT 2015

KEYNOTE LECTURE: An FDA Changing Vision for Medical Device Regulation Innovation, Speed-to-Market, Patient Safety, and Creative Clinical Research Pathways

Presenter: Roxana Mehran, Bram D. Zuckerman, Aaron V. Kaplan, Jeffrey Shuren

October 13, 2015

Presentation TCT 2015

Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence

Presenter: Ajay J. Kirtane, Roxana Mehran, Sanjay Kaul

October 12, 2015

Presentation TCT 2015

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Clinician/Trialist Perspective

Presenter: Ajay J. Kirtane, Roxana Mehran, Robert A. Harrington

October 12, 2015

Presentation TCT 2015

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Statistical Perspective

Presenter: Ajay J. Kirtane, Roxana Mehran, Eugene H. Blackstone

October 12, 2015

Presentation TCT 2015

Keynote Lecture 2: The Case for (and the Arguments Against) Moving Quality-of-Life Assessment Front and Center in Clinical Trials

Presenter: Ajay J. Kirtane, Roxana Mehran, John A. Spertus

October 12, 2015

Presentation TCT 2015

Keynote Lecture 1: Advantages, Pitfalls, and Analysis Options for Composite Endpoints

Presenter: Ajay J. Kirtane, Roxana Mehran, Stuart J. Pocock

October 12, 2015

Presentation TCT 2015

HOT TOPIC 5: Debate Patient-Centered/-Reported Outcomes in Device Studies: How Will This Shape the Future of Clinical Studies? Con Level of Evidence Is Weak!

Presenter: Ajay J. Kirtane, Roxana Mehran, Daniel I. Simon

October 12, 2015

Presentation TCT 2015

HOT TOPIC 5: Debate Patient-Centered/-Reported Outcomes in Device Studies: How Will This Shape the Future of Clinical Studies? Pro The Patient Matters Most!

Presenter: Ajay J. Kirtane, Roxana Mehran, Suzanne V. Arnold

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: OrbusNeich Combo

Presenter: Pieter C. Smits, Philip M. Urban, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Insights From BioImage: Vulnerable Plaque Is a Systemic Disease

Presenter: Gregg W. Stone, Renu Virmani, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies Focused Commentary

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, Roxana Mehran

October 12, 2015

Presentation TCT 2015

A Tribute to Liliana Grinfeld

Presenter: Dimitrios Alexopoulos, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Top 10 Lessons for Complication-Free TAVR

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Philippe Généreux

October 11, 2015

Advertisement

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Big Data: Opportunities and Challenges 4 Academia Perspectives

Big Data: Opportunities and Challenges 3 Industry Perspectives

Big Data: Opportunities and Challenges 2 EMA Perspectives

Big Data: Opportunities and Challenges 1 FDA Perspectives

Is the Answer Pragmatic/Simple Trials? Are They Really So Simple?

KEYNOTE LECTURE: Redefining Clinical Research and Patient Care: The New Era of Big Data, Precision Medicine, and Digital Health

KEYNOTE LECTURE: An FDA Changing Vision for Medical Device Regulation Innovation, Speed-to-Market, Patient Safety, and Creative Clinical Research Pathways

Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Clinician/Trialist Perspective

HOT TOPIC 6: Importance of Evaluating Competing and Recurrent Events Within Clinical Trials Statistical Perspective

Keynote Lecture 2: The Case for (and the Arguments Against) Moving Quality-of-Life Assessment Front and Center in Clinical Trials

Keynote Lecture 1: Advantages, Pitfalls, and Analysis Options for Composite Endpoints

HOT TOPIC 5: Debate Patient-Centered/-Reported Outcomes in Device Studies: How Will This Shape the Future of Clinical Studies? Con Level of Evidence Is Weak!

HOT TOPIC 5: Debate Patient-Centered/-Reported Outcomes in Device Studies: How Will This Shape the Future of Clinical Studies? Pro The Patient Matters Most!

Device and Clinical Program Highlights: OrbusNeich Combo

Insights From BioImage: Vulnerable Plaque Is a Systemic Disease

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies Focused Commentary

A Tribute to Liliana Grinfeld

Top 10 Lessons for Complication-Free TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content